Aurobindo Pharma Limited has submitted a regulatory disclosure to the Listing Department of the National Stock Exchange of India Limited and The Corporate Relations Department of BSE Limited regarding its participation in an investor/analyst meeting.
The company officials will participate in the Nuvama India Conference 2026 – Singapore & Hong Kong, which is scheduled to take place from August 11 to 13, 2026. The meetings will be held daily from 9:00 AM to 6:00 PM (GMT +8 timezone).
The meeting format will include in-person group meetings to be conducted in Singapore and Hong Kong. The company specifically notes that the schedule is subject to change due to exigencies on the part of either the Investor or the Company.
A critical disclosure states that no unpublished price sensitive information (UPSI) is intended to be discussed during these interactions with investors and analysts.
The document was digitally signed by B. Adi Reddy, Company Secretary of Aurobindo Pharma Limited, on August 6, 2026, at 17:52:03 IST. The company's corporate office is located at Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032, Telangana, India.